Evommune, Inc. (New York Stock Exchange:EVMN)
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Loses money on what it sells.
- Revenue
- $10.0M
- Net income
- -$94.7M
- Net margin
- -946.7%
Little or no net debt.
- Total debt
- $8.1M
- Cash
- $60.0M
- Debt / equity
- 0.03
Comfortably covers what is due within a year.
- Current assets
- $204.2M
- Current liabilities
- $17.5M
- Current ratio
- 11.68
Consumes cash and must keep raising it.
- Operating cash flow
- -$74.2M
- Free cash flow
- -$74.7M
- FCF margin
- -746.5%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 36.1M
- Share growth (1y)
- 20.1%
- Cash runway
- 10 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
EVMN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 10.00 M | 0.00 | 3.00 M |
| Revenue Growth (YoY) | — | -100.00 % | — | — | — | -57.14 % |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 375.00 K | 377.00 K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 10.00 M | -375.00 K | 2.62 M |
| SG&A Expense | 8.48 M | 6.63 M | 9.31 M | 3.69 M | 3.36 M | 3.29 M |
| R&D Expense | 26.41 M | 17.32 M | 20.40 M | 19.64 M | 19.64 M | 14.36 M |
| Operating Expenses | 34.90 M | 23.95 M | 29.72 M | 23.33 M | 22.62 M | 17.66 M |
| Operating Income | -34.90 M | -23.95 M | -29.72 M | -13.33 M | -22.99 M | -15.03 M |
| Pretax Income | -32.25 M | -21.67 M | -28.27 M | -12.47 M | -13.56 M | -14.56 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -32.25 M | -21.67 M | -28.27 M | -12.47 M | -13.56 M | -14.56 M |
| EPS (Basic) | -0.89 | -0.64 | -1.43 | -0.41 | -0.45 | -0.48 |
| EPS (Diluted) | -0.89 | -0.64 | -1.43 | -0.41 | -0.45 | -0.48 |
| Shares Outstanding | 36.14 M | 33.67 M | 19.78 M | 30.08 M | 30.08 M | 30.08 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.